Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-22-017392

Chief Operating Officer sold 1,244 shares at $12.01 ($14,940)

  • Chief Operating Officer acquired 74,135 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
ADAMS R MARK Chief Operating Officer 2022-03-04 Grant or award +74,135 124,968 D: show line 1 in the form
ADAMS R MARK Chief Operating Officer 2022-03-07 Sale −1,244 $12.01 $14,940 123,724 D: show line 2 in the form
Open-market sales · 1,244 sh · avg $12.01 · $14,940

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
ADAMS R MARK Chief Operating Officer 2022-03-04 Grant or award · Stock Option (Right to Buy) +185,338 185,338 D: show line 3 in the form
Loading xslF345X03/doc4.xml…